title: In vitro, in vivo and in silico models of drug distribution into the brain.
abstract: Achieving sufficient brain penetration to elicit efficacy in humans is one of the most challenging tasks for scientists in CNS Drug Discovery. Substantial progress has been made in the past decade in understanding the factors influencing the rate and extent of brain distribution via a variety of in vivo, in vitro and in silico methodologies, and hence, predict their likelihood of success in man. This purpose of this review is to summarize the current approaches with a special focus on parameters related to free drug concentrations in brain which are the most pharmacologically relevant for the majority of CNS disease targets. Due to the dynamic and complex nature of this targeted organ, it is inevitable that these approaches have not been able to provide a fully comprehensive assessment of brain distribution and are expected to evolve further in the years to come.
authors: GlaxoSmithKine R&D, Sir David Jack Research Centre, Ware, SG12 0DP, Hertfordshire, United Kingdom. scott.g.summerfield@gsk.com
authors: Scott G
authors: SG
authors: Summerfield
authors: Kelly C
authors: KC
authors: Dong
mesh_terms: D000818:Animals; D001921:Brain / Q000378:metabolism*; D002460:Cell Line; D002491:Central Nervous System Agents / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics*; D055808:Drug Discovery / Q000379:methods*; D006801:Humans; D008954:Models, Biological; D013329:Structure-Activity Relationship; D013379:Substrate Specificity; D014018:Tissue Distribution
chemical_list: D002491:Central Nervous System Agents
references: Epilepsia. 2007 Mar;48(3):505-16
references: 17326793
references: Pharm Res. 2001 Jul;18(7):957-63
references: 11496955
references: Drug Metab Dispos. 2011 Mar;39(3):353-62
references: 21149540
references: Curr Pharm Des. 2004;10(12):1295-312
references: 15134482
references: Br J Clin Pharmacol. 2012 Feb;73(2):175-86
references: 21838787
references: Drug Metab Dispos. 2011 May;39(5):814-9
references: 21325432
references: Eur J Pharm Sci. 2009 Sep 10;38(2):121-37
references: 19591928
references: Drug Metab Dispos. 2010 Jan;38(1):168-76
references: 19833843
references: Pharmacol Rev. 2005 Jun;57(2):173-85
references: 15914466
references: J Pharm Sci. 2011 Sep;100(9):3577-93
references: 21544824
references: Drug Metab Dispos. 2009 Feb;37(2):315-21
references: 19029202
references: Biochem Pharmacol. 2004 Jan 15;67(2):269-76
references: 14698039
references: J Pharmacol Exp Ther. 2011 Dec;339(3):935-44
references: 21934030
references: Eur J Pharmacol. 2003 Jan 24;460(2-3):85-91
references: 12559367
references: Int J Pharm. 2005 Jan 20;288(2):349-59
references: 15620875
references: Mol Pharm. 2010 Oct 4;7(5):1805-15
references: 20795735
references: Anesthesiology. 2008 Mar;108(3):495-505
references: 18292687
references: Eur J Pharm Sci. 2005 Jan;24(1):49-57
references: 15626577
references: J Cereb Blood Flow Metab. 2009 Jul;29(7):1293-304
references: 19458607
references: Neurosci Biobehav Rev. 2012 Apr;36(4):1188-216
references: 22342372
references: Drug Discov Today. 2011 Aug;16(15-16):704-14
references: 21624498
references: Nat Rev Drug Discov. 2007 Jul;6(7):521-32
references: 17599084
references: Mol Pharm. 2011 Apr 4;8(2):571-82
references: 21309545
references: Nat Rev Drug Discov. 2010 Mar;9(3):215-36
references: 20190787
references: PLoS One. 2011;6(10):e25815
references: 21991360
references: Br J Pharmacol. 2009 Jul;157(6):1085-96
references: 19438510
references: J Pharmacol Exp Ther. 2005 Jun;313(3):1254-62
references: 15743928
references: J Cereb Blood Flow Metab. 2011 Jan;31(1):250-61
references: 20571525
references: Am J Physiol Heart Circ Physiol. 2000 Sep;279(3):H1022-8
references: 10993764
references: J Pharm Sci. 2006 Sep;95(9):1944-53
references: 16850390
references: J Cereb Blood Flow Metab. 2012 May;32(5):874-83
references: 22274741
references: Mol Pharm. 2011 Jun 6;8(3):651-63
references: 21438632
references: Exp Neurol. 2002 Apr;174(2):193-200
references: 11922661
references: J Neurochem. 1992 Jan;58(1):1-17
references: 1727421
references: Drug Discov Today. 2012 May;17(9-10):419-24
references: 22227532
references: J Pharm Sci. 2009 Jun;98(6):1980-91
references: 18837012
references: Drug Metab Dispos. 2004 Jan;32(1):132-9
references: 14709630
references: J Med Chem. 2009 Oct 22;52(20):6233-43
references: 19764786
references: Lab Invest. 2005 Jun;85(6):734-46
references: 15908914
references: Pharm Res. 2002 Jul;19(7):976-81
references: 12180550
references: Molecules. 2012 Aug 31;17(9):10429-45
references: 22941223
references: Drug Discov Today. 2012 Aug;17(15-16):905-12
references: 22507594
references: Neurochem Int. 2009 Mar-Apr;54(3-4):253-63
references: 19111869
references: J Comput Aided Mol Des. 2011 Dec;25(12):1095-106
references: 22109848
references: Drug Metab Dispos. 2006 Feb;34(2):318-23
references: 16303872
references: Drug Metab Lett. 2012 Jun 1;6(2):134-44
references: 23061481
references: Curr Top Med Chem. 2009;9(2):130-47
references: 19200001
references: Drug Metab Dispos. 2006 Sep;34(9):1443-7
references: 16760229
references: J Pharmacol Exp Ther. 2006 Mar;316(3):1282-90
references: 16330496
references: PLoS One. 2012;7(3):e33829
references: 22439003
references: Xenobiotica. 2007 Oct-Nov;37(10-11):1135-51
references: 17968740
references: Eur J Pharm Sci. 2008 Oct 2;35(3):161-74
references: 18656534
references: Drug Metab Dispos. 2008 Feb;36(2):268-75
references: 17962372
references: Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):215-20
references: 20050843
references: J Pharm Sci. 2008 Aug;97(8):3433-41
references: 17990306
references: Psychiatry Res. 1988 Jan;23(1):1-10
references: 3363012
references: Methods Mol Med. 2003;89:193-208
references: 12958421
references: Drug Metab Dispos. 2009 Jun;37(6):1226-33
references: 19299522
references: Pharm Res. 1988 Jun;5(6):369-71
references: 3244648
references: Curr Opin Drug Discov Devel. 2005 Jul;8(4):505-12
references: 16022187
references: J Pharmacol Exp Ther. 2007 Jul;322(1):205-13
references: 17405866
references: Pharm Res. 2011 Mar;28(3):517-30
references: 21042838
references: J Mol Graph Model. 2011 Aug;29(8):985-95
references: 21571561
references: AAPS J. 2005 Oct 07;7(3):E532-43
references: 16353931
references: J Nucl Med. 2008 Apr;49(4):649-56
references: 18344435
references: J Pharm Sci. 2012 Apr;101(4):1337-54
references: 22213383
references: Pharm Res. 2012 Sep;29(9):2468-76
references: 22644589
references: J Pharm Sci. 2012 Nov;101(11):4277-92
references: 22864977
references: Brain Res. 2007 May 30;1150:1-13
references: 17434463
references: Drug Metab Dispos. 2009 Apr;37(4):753-60
references: 19158315
references: Drug Discov Today. 2012 Apr;17(7-8):343-51
references: 22119877
references: Mol Pharm. 2011 Aug 1;8(4):1332-41
references: 21707071
references: J Pharmacol Exp Ther. 2011 Jan;336(1):223-33
references: 20952483
references: Pharm Res. 1997 Feb;14(2):128-34
references: 9090698
references: J Nucl Med. 2010 Sep;51(9):1447-55
references: 20720035
references: Xenobiotica. 2008 Dec;38(12):1518-35
references: 18979396
references: J Cell Sci. 1992 Sep;103 ( Pt 1):23-37
references: 1429907
references: Drug Metab Dispos. 2005 Jan;33(1):165-74
references: 15502009
references: Clin Pharmacokinet. 2002;41(10):691-703
references: 12162757
references: J Pharmacol Exp Ther. 1997 Jul;282(1):81-5
references: 9223542
references: Eur J Pharm Sci. 2012 Apr 11;45(5):685-92
references: 22306648
references: Pharmacol Biochem Behav. 2008 Aug;90(2):125-34
references: 18468668
references: Drug Metab Dispos. 2012 Oct;40(10):1909-16
references: 22736307
references: J Chem Inf Model. 2010 Jun 28;50(6):1123-33
references: 20578728
references: J Med Chem. 2007 Sep 20;50(19):4606-15
references: 17725338
references: Nat Rev Drug Discov. 2010 Dec;9(12):929-39
references: 21119731
references: Pharm Res. 2008 Aug;25(8):1737-50
references: 18058202
references: Drug Metab Dispos. 2007 Sep;35(9):1711-9
references: 17591680
references: Biopharm Drug Dispos. 2002 Nov;23(8):327-38
references: 12415573
references: Int J Pharm. 2010 Dec 15;402(1-2):27-36
references: 20920560
references: AAPS J. 2012 Sep;14(3):543-53
references: 22588644
references: Invest New Drugs. 2009 Feb;27(1):31-40
references: 18449471